Virginia is currently home to 1853 active clinical trials, seeking participants for engagement in research studies. These trials take place at a variety of cities in the state, including Richmond, Charlottesville, Norfolk and Fairfax. Whether you're a healthy volunteer interested in paid medical research or someone seeking trials related to a specific condition, the state offers a diverse array of opportunities in your vicinity.
A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE)
NCT04951219
Recruiting
A 52-Week, Multi-center, Open-label, Active Treatment Extension Study to Evaluate Safety and Tolerability of Once Daily, Oral Administration of Resmetirom (MGL-3196)
Gender:
ALL
Ages:
18 years and above
Trial Updated:
11/28/2023
Locations: Bon Secours Liver Institute of Richmond, Richmond, Virginia
Conditions: Non-Alcoholic Fatty Liver Disease
Register for Updates
Minds Navigating the Diagnosis of Mild Cognitive Impairment
NCT05690243
Recruiting
The goal of this clinical trial is to find out if a 9 week group therapy using video from home will help veterans with Mild Cognitive Impairment (MCI). The main questions it aims to answer are: * is the video therapy user-friendly for veterans? * does it improve veterans well-being and quality-of-life? Veterans will be asked to attend nine 1 hour small group video sessions and will complete questionnaires before and after the sessions. Researchers will compare the group of veterans that start... Read More
Gender:
ALL
Ages:
60 years and above
Trial Updated:
11/20/2023
Locations: Salem VA Medical Center, Salem, Virginia
Conditions: Cognitive Dysfunction, Mild Cognitive Impairment
Register for Updates
Prospective Database Registry Study of Scoliosis in Children With Cerebral Palsy
NCT00680264
Recruiting
The purpose of this study is to determine the radiographic and clinical outcomes of Scoliosis surgical and non-operative treatment in patients with Cerebral Palsy.
Gender:
ALL
Ages:
Between 8 years and 21 years
Trial Updated:
11/20/2023
Locations: Kluge Children's Rehab. Ctr., Charlottesville, Virginia
Conditions: Cerebral Palsy, Scoliosis
Register for Updates
Use of Harmonic Scalpel to Decrease Lymphatic and Chest Tube Drainage After Lymph Node Dissection With Lobectomy.
NCT00591552
Recruiting
In an effort to elucidate whether the Harmonic Scalpel will improve sealing lymphatics and decrease lymphatic drainage thereby decreasing the length of time that chest tubes are required and minimizing length of stay; the Harmonic Scalpel will be compared to a control group which uses electrocautery. This study will assess these two different methods to determine if there is a notable decrease in the amount of drainage with one versus the other.
Gender:
ALL
Ages:
Between 20 years and 75 years
Trial Updated:
11/20/2023
Locations: Sentara Norfolk General Hospital/Sentara Heart Hospital, Norfolk, Virginia
Conditions: Lung Cancer
Register for Updates
PrEP Intervention Among Black Sexual Minority Men
NCT06141408
Recruiting
The goal of the proposed research is to design a peer-based community intervention focused on addressing internalized homophobia, internalized racism, HIV stigma, and peer BSMM support to increase PrEP initiation among BSMM in Prince George's County, MD. Participants will attend intervention events focused on stigma reduction and building community among Black queer men. Researchers will compare intervention and control group participants to see if there in a difference in PrEP initiation and ad... Read More
Gender:
MALE
Ages:
18 years and above
Trial Updated:
11/15/2023
Locations: George Mason University, Fairfax, Virginia
Conditions: Hiv, Mental Health Issue, Support, Family
Register for Updates
Androgen Blockade and Progesterone Augmentation of Gonadotropin Secretion
NCT04597099
Recruiting
This study is trying to find out if flutamide (a medication that blocks the effects of testosterone) may help normalize an aspect of pituitary function (specifically, gonadotropin surge generation) in PCOS. This is a randomized, placebo-controlled, double-blinded, crossover study. The investigators hypothesize that in estradiol-pretreated women with PCOS, acute progesterone augmentation of FSH release (positive feedback) will be enhanced by flutamide.
Gender:
FEMALE
Ages:
Between 18 years and 30 years
Trial Updated:
11/01/2023
Locations: University of Virginia, Charlottesville, Virginia
Conditions: PCOS, Polycystic Ovary Syndrome
Register for Updates
Relative Desirability of Metformin vs. Birth Control Pill in Treating PCOS in Women of Later Reproductive Age
NCT03905941
Recruiting
The goal of this study is to determine the relative desirability of metformin vs. oral combined hormonal contraceptives (OCs) in treating Polycystic Ovary Syndrome (PCOS) in women of later reproductive age. Polycystic Ovary Syndrome Questionnaire (PCOSQ) score will be used as a proxy for patient satisfaction. In light of their respective effects on the classic and metabolic facets of PCOS, metformin will provide non-inferior patient satisfaction compared to OCs in later reproductive age women wi... Read More
Gender:
FEMALE
Ages:
Between 40 years and 49 years
Trial Updated:
11/01/2023
Locations: University of Virginia, Charlottesville, Virginia
Conditions: Polycystic Ovary Syndrome
Register for Updates
Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS
NCT03905603
Recruiting
The objective of the study is to determine the relative contributions of four established predictors of hyperandrogenism (luteinizing hormone \[LH\] secretion, ovarian response to recombinant human chorionic gonadotropin \[r-hCG\] administration, adrenal response to adrenocorticotropic hormone \[ACTH\] administration, and hyperinsulinemia) in older vs. young women with Polycystic Ovary Syndrome (PCOS) in a cross-sectional, physiological study. The investigators hypothesize that hyperinsulinemia... Read More
Gender:
FEMALE
Ages:
Between 20 years and 49 years
Trial Updated:
11/01/2023
Locations: University of Virginia, Charlottesville, Virginia
Conditions: Polycystic Ovary Syndrome
Register for Updates
Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome
NCT03401047
Recruiting
The purpose of this study is to determine if estradiol augmentation of luteinizing hormone (LH) secretion secretion (primary endpoint) and follicle-stimulating hormone (FSH) secretion (secondary endpoint) is reduced in adult women with polycystic ovary syndrome.
Gender:
FEMALE
Ages:
Between 18 years and 30 years
Trial Updated:
11/01/2023
Locations: University of Virginia Clinical Research Unit, Charlottesville, Virginia
Conditions: Polycystic Ovary Syndrome
Register for Updates
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
NCT03068910
Recruiting
The purpose of this study is to determine if, in mid- to late pubertal girls with hyperandrogenism, androgen-receptor blockade (spironolactone) improves the ability of progesterone to acutely reduce waking luteinizing hormone pulse frequency (primary endpoint).
Gender:
FEMALE
Ages:
Between 10 years and 17 years
Trial Updated:
11/01/2023
Locations: University of Virginia Clinical Research Unit, Charlottesville, Virginia
Conditions: Hyperandrogenism, Polycystic Ovary Syndrome, Puberty
Register for Updates
Assessment of Day-night Secretion of Progesterone and LH Across Puberty
NCT02155933
Recruiting
Hormones are substances that are made by the body and are sent directly out into the bloodstream to increase or decrease the function of certain organs, glands, or other hormones. Testosterone is a hormone found in the blood of all girls, but some girls have too much testosterone in their blood. Too much testosterone in the blood can possibly lead to a problem called polycystic ovary syndrome (PCOS). People with PCOS have abnormal menstrual periods, excess facial and body hair, and too much test... Read More
Gender:
FEMALE
Ages:
Between 7 years and 17 years
Trial Updated:
11/01/2023
Locations: Center for Research in Reproduction, University of Virginia, Charlottesville, Virginia
Conditions: Puberty, Hyperandrogenism
Register for Updates
Suppression of Daytime and Nighttime Luteinizing Hormone Frequency by Progesterone
NCT01428089
Recruiting
During childhood, the levels of certain hormones: gonadotropin-releasing hormone (GnRH), luteinizing hormone (LH), follicle-stimulating hormone (FSH), estrogen, and progesterone are very low. However, when puberty starts, GnRH and LH pulses begin to increase, but they initially do so at night only. It is unknown why GnRH and LH pulses increase at night and then decrease during the day (instead of being increased all the time). The purpose of this study is to see how quickly progesterone reduces... Read More
Gender:
FEMALE
Ages:
Between 7 years and 14 years
Trial Updated:
11/01/2023
Locations: Center for Research in Reproduction, University of Virginia, Charlottesville, Virginia
Conditions: Polycystic Ovary Syndrome, Hyperandrogenism, Normal Puberty
Register for Updates